Added to YB: 2023-12-18
Pitch date: 2023-12-18
TWST:US [bearish]
Twist Bioscience Corporation
+11.56%
current return
Author Info
No bio for this author
Company Info
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development.
Market Cap
$1.6B
Pitch Price
$35.13
Price Target
N/A
Dividend
N/A
EV/EBITDA
-16.66
P/E
-20.69
EV/Sales
3.93
Sector
Biotechnology
Category
N/A
Twist Bioscience Corp. TWST:US
A summary for this pitch has not been created yet.
Read full article (0 min)